A new study published in Clinical & Experimental Ophthalmology found that faricimab was effective in treating patients with neovascular age-related macular degeneration (nAMD) who had not previously ...
Patients with treatment-naive neovascular age-related macular degeneration have positive outcomes with faricimab at 1 year, ...
New research examined the effects of cataract surgery on visual acuity and disease activity in patients with nAMD receiving anti-VEGF treatment. The treatment intensity for underlying nAMD remained ...
Pegcetacoplan injections slowed progression of geographic atrophy but had no impact on visual acuity in a real-world setting, ...
A deep learning model may be able to outperform ophthalmologists in predicting neovascular age-related macular degeneration (nAMD) recurrence. Recurrence of neovascular age-related macular ...
The risk for neovascular age-related macular degeneration (nAMD) seems not to be increased following cataract surgery, ...
BARCELONA, Spain — Patients who receive a diagnosis of neovascular age-related macular degeneration (nAMD) from their primary care clinician may be less likely to adhere to treatment than those who ...
Exton, Pennsylvania, July 10, 2025 (GLOBE NEWSWIRE) -- Recently released research from Spherix Global Insights provides a timely look at the increasingly competitive and complex treatment landscape ...
Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III ...
Optometrists' ability to classify retinal lesions for re-treatment decisions regarding quiescent neovascular age-related macular degeneration (nAMD) is not inferior to that of ophthalmologists, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results